AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29868449 — intervention group
Group type: EXPERIMENTAL
Intervention: Boosted acupuncture
Number of subjects: 74
Study 29868449 — intervention group
Group type: COMPARATOR
Intervention: Standard acupuncture
Number of subjects: 74
Study 29868449 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 74
Study 26833397 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial-meridian release acupuncture (MMRA)
Number of subjects: 74
Study 26833397 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 74
Study 25672194 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketac Molar (GIC)
Number of subjects: 27
Study 25672194 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitremer (RMGIC)
Number of subjects: 27
Study 25672194 — intervention group
Group type: EXPERIMENTAL
Intervention: Both cements
Number of subjects: 27
Study 22077106 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilastine 20 mg
Number of subjects: 650
Study 22077106 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 650
Study 22077106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 650
Study 21117361 — intervention group
Group type: EXPERIMENTAL
Intervention: Excimer laser phototherapeutic keratectomy (PTK)
Number of subjects: 53
Study 21117361 — intervention group
Group type: COMPARATOR
Intervention: Surgical keratectomy of ulcer edge and base (Control)
Number of subjects: 53
Study 17331512 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered colonoscope (TC)
Number of subjects: 40
Study 17331512 — intervention group
Group type: COMPARATOR
Intervention: Pediatric variable‐stiffness colonoscope (PVSC)
Number of subjects: 40
Study 16279889 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg combined with clarithromycin 500 mg and amoxicillin 1 g for 1 week
Number of subjects: 200
Study 16279889 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 40 mg combined with clarithromycin 500 mg and amoxicillin 1 g for 1 week
Number of subjects: 200
Study 16279889 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study 12411798 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium group (50 mg/kg as a bolus, then 8 mg x kg(‐1) x h(‐1))
Number of subjects: 54
Study 12411798 — intervention group
Group type: COMPARATOR
Intervention: Control group (0.9% sodium chloride solution)
Number of subjects: 54
Study 12411798 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium group (propofol infusion rate maintained at 80 microg x kg(‐1) x min(‐1))
Number of subjects: 54
Study 12411798 — intervention group
Group type: COMPARATOR
Intervention: Control group (propofol infusion rate maintained at 160 microg x kg(‐1) x min(‐1))
Number of subjects: 54
Study 10470755 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional tidal volume ventilation (10-12 mL/kg ideal body weight)
Number of subjects: 52
Study 10470755 — intervention group
Group type: COMPARATOR
Intervention: Reduced tidal volume ventilation (5-8 mL/kg ideal body weight)
Number of subjects: 52
Study 10470755 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study 7784000 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K and phenobarbital
Number of subjects: 372
Study 1283851 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine (single-agent)
Number of subjects: 153
Study 1283851 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine combined with cisplatin
Number of subjects: 153
Study 3971659 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide (6 days)
Number of subjects: 26
Study 3971659 — intervention group
Group type: COMPARATOR
Intervention: Frusemide with salt replacement
Number of subjects: 26
Study 31335865 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence Clubs (ACs)
Number of subjects: 507
Study 31335865 — intervention group
Group type: EXPERIMENTAL
Intervention: Decentralized Medication Delivery (DMD)
Number of subjects: 507
Study 31335865 — intervention group
Group type: COMPARATOR
Intervention: Control (standard of care) for ACs
Number of subjects: 507
Study 31335865 — intervention group
Group type: COMPARATOR
Intervention: Control (standard of care) for DMD
Number of subjects: 507
Study 29218411 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (with clinical information)
Number of subjects: 90
Study 29218411 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (without clinical information)
Number of subjects: 90
Study 26887966 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato sauce enriched with refined olive oil (ROOE)
Number of subjects: 40
Study 26887966 — intervention group
Group type: COMPARATOR
Intervention: Tomato sauce without refined olive oil (oil-free: OF)
Number of subjects: 40
Study 25576329 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 422
Study 25576329 — intervention group
Group type: COMPARATOR
Intervention: Comparator OADs
Number of subjects: 422
Study 25576329 — intervention group
Group type: COMPARATOR
Intervention: Both cohorts
Number of subjects: 422
Study 23759203 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 31
Study 23759203 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupentixol
Number of subjects: 31
Study 19945297 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (TEA-B group, n = 13)
Number of subjects: 39
Study 19945297 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural sufentanil (TEA-S group, n = 13)
Number of subjects: 39
Study 19945297 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous remifentanil (IV-R group, n = 13)
Number of subjects: 39
Study 23344073 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of Prostaglandin E2 (250-500 µg)
Number of subjects: 50
Study 23344073 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular administration of Prostaglandin E2 (250-500 µg)
Number of subjects: 50
Study 16823366 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical warm-up
Number of subjects: 12
Study 16823366 — intervention group
Group type: EXPERIMENTAL
Intervention: Skill-specific warm-up
Number of subjects: 12
Study 16823366 — intervention group
Group type: EXPERIMENTAL
Intervention: Skill plus physical warm-up
Number of subjects: 12
Study 16823366 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 12
Study 12522370 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of calcipotriene 50 microg/g and betamethasone dipropionate 0.5 mg/g in the new vehicle
Number of subjects: 1028
Study 12522370 — intervention group
Group type: COMPARATOR
Intervention: Calcipotriene in the new vehicle
Number of subjects: 1028
Study 12522370 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone dipropionate in the new vehicle
Number of subjects: 1028
Study 12522370 — intervention group
Group type: COMPARATOR
Intervention: New vehicle alone
Number of subjects: 1028
Study 10917402 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous amitriptyline (150 mg/day)
Number of subjects: 80
Study 10917402 — intervention group
Group type: COMPARATOR
Intervention: Medium-dose intravenous amitriptyline (100 mg/day)
Number of subjects: 80
Study 10917402 — intervention group
Group type: COMPARATOR
Intervention: Oral amitriptyline (150 mg/day)
Number of subjects: 80
Study 8572635 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients
Number of subjects: 473
Study 8572635 — intervention group
Group type: COMPARATOR
Intervention: Normal weight patients
Number of subjects: 473
Study 8572635 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with axillary lymph node involvement
Number of subjects: 473
Study 8572635 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without recurrence
Number of subjects: 473
Study 8572635 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with recurrent disease
Number of subjects: 473
Study 2707124 — intervention group
Group type: EXPERIMENTAL
Intervention: bismuth subsalicylate, 1800 mg/d for four weeks
Number of subjects: 302
Study 2707124 — intervention group
Group type: EXPERIMENTAL
Intervention: amoxycillin 2250 mg/d for two weeks
Number of subjects: 302
Study 2707124 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg/d for four weeks
Number of subjects: 302
Study 2707124 — intervention group
Group type: EXPERIMENTAL
Intervention: bismuth plus amoxycillin
Number of subjects: 302
Study 2707124 — intervention group
Group type: EXPERIMENTAL
Intervention: bismuth plus ranitidine
Number of subjects: 302
Study 99226 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant MOPP chemotherapy combined with radiotherapy
Number of subjects: 440
Study 99226 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 440
Study 99226 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality therapy
Number of subjects: 440
Study 99226 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy in chemotherapy management for stage IV patients
Number of subjects: 440
Study 30371546 — intervention group
Group type: EXPERIMENTAL
Intervention: 45ICE (ice slurry ingestion)
Number of subjects: 8
Study 30371546 — intervention group
Group type: COMPARATOR
Intervention: 45FL (tepid fluid ingestion)
Number of subjects: 8
Study 28625658 — intervention group
Group type: EXPERIMENTAL
Intervention: Active high-frequency tRNS
Number of subjects: 2
Study 28625658 — intervention group
Group type: COMPARATOR
Intervention: Sham tRNS
Number of subjects: 2
Study 26789997 — intervention group
Group type: EXPERIMENTAL
Intervention: SLIToneULTRA® HDM mix at 300 standard reactivity units (SRU) for 6 months
Number of subjects: 219
Study 26789997 — intervention group
Group type: EXPERIMENTAL
Intervention: SLIToneULTRA® HDM mix at 150 SRU for 6 months
Number of subjects: 219
Study 26789997 — intervention group
Group type: EXPERIMENTAL
Intervention: SLIToneULTRA® HDM mix at 50 SRU for 6 months
Number of subjects: 219
Study 26789997 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolerability assessment of SLIToneULTRA® HDM mix
Number of subjects: 219
Study 23200784 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Bias Modification Treatment (ABMT) training towards happy faces
Number of subjects: 69
Study 23200784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 23200784 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT) only
Number of subjects: 69
Study 23200784 — intervention group
Group type: COMPARATOR
Intervention: Healthy comparison youth
Number of subjects: 69
Study 21946915 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (prophylactic daily dose starting from the positive pregnancy test)
Number of subjects: 224
Study 19192858 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher probability of winning a prize
Number of subjects: 116
Study 19192858 — intervention group
Group type: COMPARATOR
Intervention: Size of individual prizes (small, large, jumbo)
Number of subjects: 116
Study 16508259 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine infusion
Number of subjects: 97
Study 16508259 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dopamine treatment)
Number of subjects: 97
Study 12540290 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold saline (4 degrees C)
Number of subjects: 11
Study 12540290 — intervention group
Group type: COMPARATOR
Intervention: Warm saline (37 degrees C)
Number of subjects: 11
Study 10898425 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol CR/XL
Number of subjects: 394
Study 10898425 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 394
Study 8730159 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic compounds with high pKa (e.g., mecamylamine, pKa = 11.2)
Number of subjects: 12
Study 8730159 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic compounds with low pKa
Number of subjects: 12
Study 8730159 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic compounds with varying pKa
Number of subjects: 12
Study 8730159 — intervention group
Group type: EXPERIMENTAL
Intervention: High pKa compounds
Number of subjects: 12
Study 8103470 — intervention group
Group type: COMPARATOR
Intervention: Standard antiemetic regimen (control, n = 24)
Number of subjects: 121
Study 8103470 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide (HDM, n = 33)
Number of subjects: 121
Study 8103470 — intervention group
Group type: EXPERIMENTAL
Intervention: Very high dose metoclopramide (VHDM, n = 50)
Number of subjects: 121
Study 8103470 — intervention group
Group type: EXPERIMENTAL
Intervention: Very high dose metoclopramide plus droperidol (VHDM+DP, n = 14)
Number of subjects: 121
Study 3946262 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise training at home
Number of subjects: 64
Study 3946262 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise training at home
Number of subjects: 64
Study 3946262 — intervention group
Group type: COMPARATOR
Intervention: Customary activity (Control)
Number of subjects: 64
Study 29258678 — intervention group
Group type: EXPERIMENTAL
Intervention: ADF (alternate-day fasting)
Number of subjects: 100
Study 29258678 — intervention group
Group type: EXPERIMENTAL
Intervention: CR (daily calorie restriction)
Number of subjects: 100
Study 29258678 — intervention group
Group type: COMPARATOR
Intervention: Control (100% of energy needs)
Number of subjects: 100
Study 27008102 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-lasting permethrin-impregnated clothing
Number of subjects: 159
Study 27008102 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 159
Study 24346753 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DXM) 360 mg/d for 7 days
Number of subjects: 40
Study 24346753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 24346753 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DXM) 360 mg/d
Number of subjects: 40
Study 22872988 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-down tilt (HDT) at -90 degrees
Number of subjects: 21
Study 22872988 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-up tilt (HUT) at +90 degrees
Number of subjects: 21
Study 22872988 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 21
Study 20211025 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet Support Group (ISG) intervention
Number of subjects: 0
Study 20211025 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-module automated psychoeducational and skills Internet Training Program (ITP)
Number of subjects: 0
Study 20211025 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ISG and ITP
Number of subjects: 0
Study 20211025 — intervention group
Group type: COMPARATOR
Intervention: Internet Attention Control website (IAC)
Number of subjects: 0
Study 18227297 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol/Remifentanil (group PR)
Number of subjects: 50
Study 18227297 — intervention group
Group type: COMPARATOR
Intervention: Midazolam/Fentanyl (group MF)
Number of subjects: 50
Study 16433405 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc oxide‐eugenol (ZOE)
Number of subjects: 80
Study 16433405 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealapex
Number of subjects: 80
Study 16433405 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcicur
Number of subjects: 80
Study 16433405 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitapex
Number of subjects: 80
Study 12598260 — intervention group
Group type: COMPARATOR
Intervention: IV saline (placebo group; n = 20)
Number of subjects: 80
Study 12598260 — intervention group
Group type: EXPERIMENTAL
Intervention: droperidol 1 mg (dro-1 group; n = 20)
Number of subjects: 80
Study 12598260 — intervention group
Group type: EXPERIMENTAL
Intervention: droperidol 2 mg (dro-2 group; n = 20)
Number of subjects: 80
Study 10470576 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg per day for the first 3 days, 0.25 mg/kg per day for the next 3 days, 0.125 mg/kg per day on the 7th day)
Number of subjects: 50
Study 10470576 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 50
Study 10470576 — intervention group
Group type: COMPARATOR
Intervention: Control (no steroid treatment)
Number of subjects: 50
Study 8698957 — intervention group
Group type: EXPERIMENTAL
Intervention: Research engagement
Number of subjects: 0
Study 8698957 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment participation
Number of subjects: 0
Study 8698957 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term outcome
Number of subjects: 0
Study 1667472 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrophosphate/Gantrez copolymer dentifrice
Number of subjects: 150
Study 1667472 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc citrate dentifrice
Number of subjects: 150
Study 1667472 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 150
Study 6336719 — intervention group
Group type: EXPERIMENTAL
Intervention: slow‐release metoprolol 200 mg once daily
Number of subjects: 20
Study 6336719 — intervention group
Group type: COMPARATOR
Intervention: matched placebo
Number of subjects: 20
Study 6336719 — intervention group
Group type: EXPERIMENTAL
Intervention: slow‐release metoprolol
Number of subjects: 20
Study 30605458 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive suggestion regarding side effects
Number of subjects: 66
Study 30605458 — intervention group
Group type: COMPARATOR
Intervention: Control information about side effects
Number of subjects: 66
Study 30605458 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of diclofenac and atropine
Number of subjects: 66
Study 30605458 — intervention group
Group type: EXPERIMENTAL
Intervention: General Assessment of Side Effects (GASE) questionnaire
Number of subjects: 66
Study 29792472 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 46
Study 29792472 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous exercise
Number of subjects: 46
Study 29792472 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline weekly cannabis use
Number of subjects: 46
Study 26507722 — intervention group
Group type: EXPERIMENTAL
Intervention: Azilsartan medoxomil (AZL-M) 60 mg (3 × 20 mg capsules)
Number of subjects: 61
Study 26507722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 24170388 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 9946
Study 24170388 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 9946
Study 24170388 — intervention group
Group type: EXPERIMENTAL
Intervention: Hs-TnT
Number of subjects: 9946
Study 24170388 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP
Number of subjects: 9946
Study 24170388 — intervention group
Group type: EXPERIMENTAL
Intervention: GDF-15
Number of subjects: 9946
Study 22874004 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily text messages via mobile phone for 6 weeks
Number of subjects: 205
Study 19739972 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial-resistant infection (ARI) patients
Number of subjects: 1391
Study 17149758 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced counseling (EC)
Number of subjects: 297
Study 17149758 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 297
Study 14976169 — intervention group
Group type: EXPERIMENTAL
Intervention: Community intervention 'Hartslag Limburg'
Number of subjects: 0
Study 14976169 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 11466159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23201
Study 11466159 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational antidepressants (venlafaxine ER and citalopram)
Number of subjects: 23201
Study 11466159 — intervention group
Group type: EXPERIMENTAL
Intervention: Active comparators
Number of subjects: 23201
Study 11466159 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational antidepressants
Number of subjects: 23201
Study 9554338 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical bacillus Calmette-Guerin (BCG)
Number of subjects: 9
Study 9554338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 8113822 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercholesterolemic men
Number of subjects: 523
Study 8113822 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercholesterolemic men who accepted the disease label (n = 73)
Number of subjects: 523
Study 8113822 — intervention group
Group type: EXPERIMENTAL
Intervention: Deniers (n = 122)
Number of subjects: 523
Study 8113822 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercholesterolemic men who deny having hypercholesterolemia
Number of subjects: 523
Study 3289645 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation technique
Number of subjects: 16
Study 3289645 — intervention group
Group type: COMPARATOR
Intervention: Reading program (Control)
Number of subjects: 16
Study 29334530 — intervention group
Group type: EXPERIMENTAL
Intervention: Portal and antegrade arterial flush
Number of subjects: 80
Study 29334530 — intervention group
Group type: COMPARATOR
Intervention: Portal flush only
Number of subjects: 80
Study 28675578 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial intervention (bonus of 20 RMB for each ADR report and a fine of 50 RMB for withheld reports)
Number of subjects: 0
Study 26325387 — intervention group
Group type: EXPERIMENTAL
Intervention: ALB treatment
Number of subjects: 830
Study 26325387 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 830
Study 24034304 — intervention group
Group type: EXPERIMENTAL
Intervention: FOS (5 g/day)
Number of subjects: 43
Study 24034304 — intervention group
Group type: COMPARATOR
Intervention: Control (sucrose)
Number of subjects: 43
Study 21347970 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training at 50% maximal inspiratory mouth pressure (PImax)
Number of subjects: 12
Study 21347970 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle warm-up at 40% PImax
Number of subjects: 12
Study 21347970 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined inspiratory muscle training and warm-up
Number of subjects: 12
Study 21347970 — intervention group
Group type: COMPARATOR
Intervention: Inspiratory muscle training at 15% PImax (control group)
Number of subjects: 12
Study 19358790 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 150 mg/day
Number of subjects: 612